Riskpilot← Back to searchSign inGet full accessOmega Kemi AB
ABActiveOrg 5592362551Linspelsgatan 2Wholesale of chemical products · NACE 4685Est. 20200 employees
Revenue 2023
SEK 5,8M
+89% vs 2022
EBITDA margin
14.2%
+740% vs 2022
Equity ratio
27.9%
Financial strength
Net profit 2023
SEK 472K
+592% vs 2022
| Revenue | SEK 5,8M | +89% |
| EBITDA | SEK 828K | +740% |
| Net profit | SEK 472K | +592% |
| Total assets | SEK 2,1M | +209% |
| Equity | SEK 596K | +381% |
| Employees | 0 | — |
Legal name
Omega Kemi AB
Org number
5592362551
Legal form
Aktiebolag
NACE code
4685 · Wholesale of chemical products
Founded
10 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Ulfsby, Nils Johan Evert
Company purpose
Bolaget skall bedriva försäljning av kemikalier till livs- och läkemedelsindustrin och därmed förenlig verksamhet.
Address
Linspelsgatan 2
Email
info@novakem.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 30 | 1 607 | 3 095 | 5 834 |
| Staff expenses | — | −361 | −1 008 | −1 148 |
| EBITDA | −12 | 57 | 99 | 828 |
| Depreciation & amort. | −0 | −6 | −10 | −9 |
| EBIT | −12 | 51 | 88 | 819 |
| Net financials | — | −0 | −1 | −19 |
| Profit before tax | −12 | 51 | 87 | 597 |
| Tax | −0 | −10 | −19 | −125 |
| Net profit | −12 | 40 | 68 | 472 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 38 | 289 | 690 | 2 133 |
| Equity | 13 | 53 | 124 | 596 |
| Long-term debt | 0 | 7 | 7 | 7 |
| Short-term debt | 25 | 229 | 560 | 1 327 |
| Total debt | 25 | 236 | 567 | 1 334 |
EBITDA margin
14.2%
This company
15.8%
Market median
-10% vs market
20202023
Equity ratio
27.9%
This company
38.2%
Market median
-27% vs market
20202023
Return on equity
79.2%
This company
18.4%
Market median
+330% vs market
20202023
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20202023
Asset turnover
2.74×
This company
1.12×
Market median
+145% vs market
20202023
Debt / equity
2.58×
This company
0.62×
Market median
-316% vs market
20202023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
PA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2025 – 2025 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Omega Kemi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Anders Stefan Andersson | Deputy Chief Executive Officer | 0 companies |
| Nils Johan Evert Ulfsby | Chief Executive Officer | 0 companies |
| Helmut Kemmeter | Deputy Board Member | 0 companies |
| Wilhelm Leinad Wilson | Deputy Board Member | 0 companies |
| L Christopher J Lawrence-Brown | Board of Directors | 0 companies |